Addressing clinical trials: Can the Multidisciplinary Tumor Board improve participation? A study from an academic women's cancer program

Gynecologic Oncology

Volumn 116, Issue 3, 2010, Pages 295-300

  Kuroki, Lindsay ^a   Stuckey, Ashley ^a,b   Hirway, Priya ^a   Raker, Christina A ^a   Bandera, Christina A ^a,b   DiSilvestro, Paul A ^a,b   Granai, Cornelius O ^a,b   Legare, Robert D ^a,b   Sakr, Bachir J ^a,b   Dizon, Don S ^a,b  

^a BROWN UNIVERSITY   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

Cervical cancer; Clinical trials; Endometrial cancer; Gynecologic oncology; Ovarian cancer; Tumor board

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RESEARCH; CANCER THERAPY; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; FEMALE; GYNECOLOGY; HEALTH PROGRAM; HUMAN; INTERDISCIPLINARY RESEARCH; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MEDICAL SOCIETY; ONCOLOGY; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; WOMEN'S HEALTH;

ADOLESCENT; ADULT; CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; FEMALE; GENITAL NEOPLASMS, FEMALE; GYNECOLOGY; HUMANS; MEDICAL ONCOLOGY; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SELECTION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 75749158454     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.12.005     Document Type: Article

References (25)

1. The American College of Surgeons Commission on Cancer: Cancer Program Standards 2009 Revised Edition. Available from: URL: www.facs.org/cancer/coc/cocprogramstandards.pdf [accessed April 30, 2009].
2. Henson D.E., Frelick R.W., Ford L.G., et al. Results of a national survey of characteristics of hospital tumor conferences. Surg Gynecol Obstet 170 1 (Jan 1990) 1-6
3. Petty J.K., and Vetto J.T. Beyond doughnuts: tumor board recommendations influence patient care. J Cancer Educ 17 2 (Summer 2002) 97-100
4. Chang J.H., Vines E., Bertsch H., et al. The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience. Cancer 91 7 (Apr 1 2001) 1231-1237
5. Santoso J.T., Schwertner B., Coleman R.L., and Hannigan E.V. Tumor board in gynecologic oncology. Int J Gynecol Cancer 14 2 (Mar-Apr 2004) 206-209
6. Newman E.A., Guest A.B., Helvie M.A., et al. Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board. Cancer 107 10 (Nov 15 2006) 2346-2351
7. Bakemeier R.F., Beck S., and Murphy J.R. Educational and consultative functions, topics, and methods of hospital general tumor conferences. J Cancer Educ 9 4 (Winter 1995) 217-225
8. Gross G.E. The role of the tumor board in a community hospital. CA Cancer J Clin 37 2 (Mar-Apr 1987) 88-92
9. Radecki S.E., Nyquist J.G., Gates J.D., Abrahamson S., and Henson D.E. Educational characteristics of tumor conferences in teaching and non-teaching hospitals. J Cancer Educ 9 4 (Winter 1995) 204-216
10. Chekerov R., Denkert C., Boehmer D., et al. Online tumor conference in the clinical management of gynecological cancer: experience from a pilot study in Germany. Int J Gynecol Cancer 18 1 (Jan-Feb 2008) 1-7
11. Tejeda H.A., Green S.B., Trimble E.L., et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst 88 12 (Jun 19 1996) 812-816
12. Lara Jr. P.N., Higdon R., Lim N., et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 19 6 (Mar 15 2001) 1728-1733
13. Nott L., Yeend S., Pirc L., Pittman K., Patterson K., and Price T.J. Successfully improving access and accrual to oncology clinical trials. Cancer 109 8 (Apr 15 2007) 1451-1453
14. Grunfeld E., Zitzelsberger L., Coristine M., and Aspelund F. Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates. Cancer 95 7 (Oct 1 2002) 1577-1583
15. Markman M., Petersen J., and Montgomery R. Influence of tumor type, disease status, and patient age on self-reported interest regarding participation in cancer clinical trials. Cancer 107 4 (Aug 15 2006) 849-853
16. Siminoff L.A., Zhang A., Colabianchi N., Sturm C.M., and Shen Q. Factors that predict the referral of breast cancer patients onto clinical trials by their surgeons and medical oncologists. J Clin Oncol 18 6 (Mar 2000) 1203-1211
17. Harrison J.D., Carter J., Young J.M., and Solomon M.J. Difficult clinical decisions in gynecological oncology: identifying priorities for future clinical research. Int J Gynecol Cancer 16 1 (Jan-Feb 2006) 1-7
18. Mannel R., Walker J., Gould N., et al. Impact of individual physician on enrollment of patients into clinical trials. Am J Clin Oncol (CCT) 26 2 (2003) 171-173
19. Patel A., Wilke II H.J., Mingay D., and Ellis J.E. Patient attitudes toward granting consent to participate in perioperative randomized clinical trials. J Clin Anesth 16 6 (Sep 2004) 426-434
20. Markman M. Providing research participants with findings from completed cancer-related clinical trials: not quite as simple as it sounds. Cancer 106 7 (Apr 1 2006) 1421-1424
21. Comis R.L., Miller J.D., Aldige C.R., Krebs L., and Stoval E. Public attitudes toward participation in cancer clinical trials. J Clin Oncol 21 5 (Mar 1 2003) 830-835
22. Sateren W.B., Trimble E.L., Abrams J., et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 20 8 (Apr 15 2002) 2109-2117
23. Vist G.E., Hagen K.B., Devereaux P.J., Bryant D., Kristoffersen D.T., and Oxman A.D. Systematic review to determine whether participation in a trial influences outcome. BMJ 330 7501 (May 21 2005) 1175
24. Stiller C.A. Centralised treatment, entry to trials and survival. Br J Cancer 70 2 (Aug 1994) 352-362
25. Djulbegovic B., Kumar A., Soares H.P., et al. Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006. Arch Intern Med 168 6 (Mar 24 2008) 632-642